These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32179362)

  • 1. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
    Yoo GS; Yu JI; Cho S; Jung SH; Han Y; Park S; Oh Y; Lee B; Park HC; Lim DH; Choi MS; Won H
    Radiother Oncol; 2020 May; 146():187-193. PubMed ID: 32179362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
    Mishra MV; Khairnar R; Bentzen SM; Larson G; Tsai H; Sinesi C; Vargas C; Laramore G; Rossi C; Rosen L; Zhu M; Hartsell W
    Clin Transl Radiat Oncol; 2019 Nov; 19():80-86. PubMed ID: 31650043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
    Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
    Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.
    Seo SH; Yu JI; Park HC; Yoo GS; Choi MS; Rhim H; Lee MW; Han S; Park B; Shim JS
    Anticancer Res; 2024 May; 44(5):2219-2230. PubMed ID: 38677752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
    Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
    J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.
    Cheng JY; Huang BS; Chen YY; Wang CC; Chen YH
    Anticancer Res; 2023 Mar; 43(3):1361-1371. PubMed ID: 36854503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.
    Pfeiler T; Ahmad Khalil D; Ayadi M; Bäumer C; Blanck O; Chan M; Engwall E; Geismar D; Peters S; Plaude S; Spaan B; Timmermann B; Wulff J
    Phys Med Biol; 2018 Nov; 63(23):235006. PubMed ID: 30468685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
    Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
    Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
    Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
    Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    Lin SY; Chen CM; Huang BS; Lai YC; Pan KT; Lin SM; Chu SY; Tseng JH
    PLoS One; 2021; 16(3):e0249003. PubMed ID: 33755701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
    Matsuda M; Mizumoto M; Kohzuki H; Sugii N; Sakurai H; Ishikawa E
    Radiat Oncol; 2023 Feb; 18(1):38. PubMed ID: 36823671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
    Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
    Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.
    Sekino Y; Tateishi R; Fukumitsu N; Okumura T; Maruo K; Iizumi T; Numajiri H; Mizumoto M; Minami T; Nakagomi R; Sato M; Asaoka Y; Nakagawa H; Hayata Y; Fujiwara N; Shiina S; Koike K; Sakurai H
    Liver Cancer; 2023 Sep; 12(4):297-308. PubMed ID: 37817755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.